ArticleBMC cancer2023

Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study.

Fei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.